Eloxx Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Eloxx Pharmaceuticals

09/11/2021 09:46

* Eloxx Pharmaceuticals Inc  ELOX.OQ  reported a quarterly
adjusted loss of 11 cents​​ per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of 13 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Eloxx Pharmaceuticals Inc's reported EPS for the quarter was a
loss of 11 cents​.
* The mean earnings estimate of analysts had fallen by
about 10.2% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Eloxx Pharmaceuticals Inc shares had fallen by 14.7% this
quarter and lost 65.1% so far this year.
* The company reported a quarterly loss of $9.89 million.
* Wall Street's median 12-month price target for Eloxx
Pharmaceuticals Inc is $3.55 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 9 at 09:46 a.m.
 ​All figures in US dollars unless otherwise stated